NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Monday reported a loss of $33.1 million in its third quarter.
The Newton, Massachusetts-based company said it had a loss of $3.82 per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $3.30 per share.
The pharmaceutical company posted revenue of $44 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $42.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
